“G-Protein Coupled Receptors (GPCRs): A Potential Target of Apigenin As a Novel HACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients”. 2025. European Journal of Pharmaceutical Research 5 (1): 6-15. https://doi.org/10.24018/ejpharma.2025.5.1.85.